Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945818 | 0.81 | MAOA (0.59) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL8872043 | 0.81 | ALDH1A1 (0.56) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL10970697 | 0.81 | ALDH1A1 (0.56) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL4423311 | 0.80 | ALDH1A1 (0.60) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL2033893 | 0.80 | ALDH1A1 (0.51) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL74692 | 0.79 | CYP1A2 (0.62) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL9582990 | 0.78 | MEN1 (0.49) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL3267301 | 0.77 | ALDH1A1 (0.56) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL258555 | 0.77 | ALDH1A1 (0.58) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL9690178 | 0.77 | ALDH1A1 (0.58) | ALDH1A1TSHRL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603906-A2 | PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ALPHA V BETA 3 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LTD. (GB) | 2005-12-14 | — | — | EP | claimed |
| WO-2004078109-A2 | PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 2004-09-16 | — | — | WO | claimed |
| WO-2024064769-A1 | INDUCTION OF STEM-LIKE ACTIVATED T CELLS | PHIO PHARMACEUTICALS CORP. (US) | 2024-03-28 | — | — | WO | disclosed |
| EP-3319614-A1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | RXi Pharmaceuticals Corporation (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3191500-A2 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS | Academia Sinica (TW) | 2017-07-19 | — | — | EP | disclosed |
| EP-3149015-A1 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | Memorial Sloan-Kettering Cancer Center (US) | 2017-04-05 | — | — | EP | disclosed |
| WO-2017007813-A1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | RXI PHARMACEUTICALS CORPORATION (US) | 2017-01-12 | — | — | WO | disclosed |
| WO-2016100444-A1 | TREATMENT OF CLOSED HEAD INJURY AND HEMORRHAGIC STROKE WITH HBED | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016040369-A2 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS | ACADEMIA SINICA (TW) | 2016-03-17 | — | — | WO | disclosed |
| WO-2015184451-A1 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2015-12-03 | — | — | WO | disclosed |
| EP-2935242-A2 | METHODS OF INHIBITING PRMT5 | Epizyme, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2005044308-A1 | PHOSPHONATE ANALOGS OF ANTIMETABOLITES | GILEAD SCIENCES, INC. (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2004096286-A2 | ANTIVIRAL PHOSPHONATE ANALOGS | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004096285-A2 | ANTI-INFECTIVE PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004096287-A2 | INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITORY PHOSPHONATE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004096233-A2 | NUCLEOSIDE PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| EP-1353923-A1 | IMPROVED PROCESS FOR CARBAPENEM SYNTHESIS | Merck & Co., Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-1294686-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002057266-A1 | IMPROVED PROCESS FOR CARBAPENEM SYNTHESIS | MERCK & CO., INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| WO-2001096299-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |